Acquiring Company
Biomapas
Acquired Company
X Cor Therapeutics
Description
Biomapas has entered the US market by acquiring the CMC business of Alira Health. This acquisition allows Biomapas to establish its new North America business and enhance its service offerings to support clients in the biopharmaceutical sector.
Other recent acquisitions in Biotechnology and Health Care
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Nuformix proposes merger with Biovara (November 11, 2026)
- Valo Health merges with Montai Therapeutics (November 11, 2026)
- Labcorp completes Millennium Health acquisition (November 9, 2026)
- Abeona Therapeutics to Acquire APT-1011 Assets from Ellodi Pharmaceuticals (November 9, 2026)
- Acrivon Therapeutics Acquires Aqilion’s Drug Development Programs (November 6, 2026)
- Vantive Enters Agreement to Divest Majority of Hemodialysis Assets to Rockwell Medical to Focus on Home Dialysis. (November 4, 2026)
Who to call at Biomapas, and when
When Biomapas changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Biomapas raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biomapas, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biomapas. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biomapas makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired X Cor Therapeutics?
X Cor Therapeutics was acquired by Biomapas, based in Lithuania. The deal was reported on November 16, 2026. Biomapas is a Lithuanian-headquartered life sciences services provider. The company operates across clinical trials, pharmacovigilance, medical information, regulatory affairs and medical writing. Biomapas is privately held and operates in Biotechnology.
When did Biomapas acquire X Cor Therapeutics?
Biomapas's acquisition of X Cor Therapeutics was reported on November 16, 2026. Biomapas has entered the US market by acquiring the CMC business of Alira Health. This acquisition allows Biomapas to establish its new North America business and enhance its service offerings to support clients in the biopharmaceutical sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does X Cor Therapeutics do?
Alira Health is an international patient-centric and technology-enabled advisory firm on the frontlines of healthcare transformation. It is privately held, and is based in Framingham.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.